CompaniesMetaboMed

MetaboMed

defunct
About

Defunct Company

Areas of Focus

Categories

Bankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (2)
View all

Total Trials

2

As Lead Sponsor

1

As Collaborator

1

Total Enrollment

80

By Phase

NA: 1PHASE1: 1

By Status

NOT_YET_RECRUITING: 1UNKNOWN: 1
Clinical Trials Pipeline2 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
NCT04990739
NCT06755008
Hover over trial bars to see details

Recent Trials

NCT06755008Collaborator
Benefits of Epithelial Repair in COPD by Induced Pluripotent Stem Cells (iPS)
NANot yet recruiting
50 participants
Started: Jan 1, 2025 · Completed: Jan 1, 2027
NCT04990739Lead Sponsor
Study of MTB-9655, an Inhibitor of ACSS2, in Patients With Advanced Solid Tumors
PHASE1Unknown
30 participants
Started: Jun 30, 2021 · Completed: Jan 31, 2024